Valuation SMAIO

Stocks

Market Closed - Euronext Paris 19:55:00 12/08/2026 +04			5-day change	1st Jan Change
7.600 ^EUR	+0.53%		-1.81%	+21.60%

07-16	SMAIO Reports Group Sales Results for the Second Quarter and First Half Ended June 30, 2026	CI
07-16	SMAIO Continued Expansion of the Network in the United States, with 5 New Centers Added to the Network and 13 New Surgeons Who Have Performed Their First Implants	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	16.99	16.1	13.46	35.24	42.81	-	-
Change	-	-5.23%	-16.43%	161.89%	21.46%	-	-
Enterprise Value (EV) ¹	11.95	12.4	12.54	34.26	41.31	41.91	42.61
Change	-	3.81%	1.07%	173.25%	20.58%	1.45%	1.67%
P/E	-	15.2x	-5.73x	-15.2x	-19.5x	190x	35.3x
PBR	-	-	-	-	6.91x	6.91x	5.85x
PEG	-	-	0x	1.71x	4x	-2x	0x
Capitalization / Revenue	7.08x	2.99x	2.45x	3.83x	3.89x	2.68x	2.05x
EV / Revenue	4.98x	2.3x	2.28x	3.72x	3.76x	2.62x	2.04x
EV / EBITDA	-4.7x	6.02x	-7.16x	-28.1x	-37.6x	28.9x	16.7x
EV / EBIT	-2.99x	16.8x	-3.94x	-13x	-15.9x	-279x	53.3x
EV / FCF	2.34x	-9.16x	-4.19x	-26.5x	-15x	-33.5x	-426x
FCF Yield	42.7%	-10.9%	-23.8%	-3.78%	-6.66%	-2.98%	-0.23%
Dividend per Share ²	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-
EPS ²	-	0.2024	-0.45	-0.41	-0.39	0.04	0.215
Distribution rate	-	-	-	-	-	-	-
Net sales ¹	2.4	5.383	5.498	9.2	11	16	20.9
EBITDA ¹	-2.544	2.059	-1.751	-1.22	-1.1	1.45	2.55
EBIT ¹	-4	0.7368	-3.184	-2.628	-2.6	-0.15	0.8
Net income ¹	2.846	1.058	-2.349	-2.229	-2.25	0.25	1.2
Net Debt ¹	-5.044	-3.7	-0.921	-0.9873	-1.5	-0.9	-0.2
Reference price ²	3.250	3.080	2.580	6.250	7.600	7.600	7.600
Nbr of stocks (in thousands)	5,229	5,229	5,216	5,639	5,633	-	-
Announcement Date	11/04/23	29/04/24	24/04/25	27/04/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SMAIO	-19.38x	3.73x	-37.35x	-	49.14M
ELI LILLY AND COMPANY	34.45x	12.59x	25.62x	0.57%	1,083B
JOHNSON & JOHNSON	28.9x	-	-	2.07%	626B
ABBVIE INC.	31.93x	7.43x	15.44x	2.74%	442B
ROCHE HOLDING AG	20.56x	4.87x	12.07x	2.71%	363B
NOVARTIS AG	22.02x	5.7x	14.21x	2.82%	295B
ASTRAZENECA PLC	20.5x	4.23x	12.01x	2.08%	248B
AMGEN INC.	25.99x	6.83x	12.15x	2.43%	224B
NOVO NORDISK A/S	13.93x	4.99x	10.37x	3.65%	210B
GILEAD SCIENCES, INC.	-42.16x	6.03x	34.04x	2.43%	168B
Average	13.67x	6.27x	10.95x	2.39%	365.92B
Weighted average by Cap.	24.65x	8.25x	18.71x	1.96%